Exosome-based candidates move into the clinic

Exosomes — small extracellular vesicles that are shed by cells — have long offered promise as drug delivery systems for small molecules, DNA, RNA and other biologic payloads. The first of these are now in the clinic.

Search for this author in:

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 20, 6-7 (2021)

Updates & Corrections

  • Clarification 17 December 2020: The description of the first agent from Codiak to enter clinical trials has been updated to ‘engineered exosome-based therapeutic’ to distinguish it from non-engineered exosome-based therapeutics, which are not the focus of the article.

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.